<DOC>
	<DOCNO>NCT02835872</DOCNO>
	<brief_summary>There need assess LDL-C-lowering ability dietary fiber ingredient , order confirm product 's efficacy . Thus , objective study assess effect 3g dietary fiber lower serum LDL-C otherwise healthy men woman .</brief_summary>
	<brief_title>A Study Evaluate Effects Dietary Fiber Blood Lipids Men Women</brief_title>
	<detailed_description>This study assess effect 3g/d dietary fiber ingredient lower serum LDL-C otherwise healthy men woman . Subjects generally healthy men woman ( approximately equal number men woman ) 21-79 year age , inclusive , fast LDL-C level ≥130 mg/dL &lt; 190 mg/dL . This randomize , control , 28-day parallel study include one screen Visit ( Visit 1 , Day -14 ) , two baseline visit ( Visits 2 3 ; Days -3 0 ) three test visit ( Visits 4 , 5 , 6 ; Days 14 , 25 , 28 ) , two contact reminder ( Days 7 21 ) . Study ingredient provide three serving study product day . During study , subject instruct consume one serving study product mealtime . The primary outcome variable percent change LDL-C concentration baseline ( average Days -3 0 ) end intervention condition ( average Days 25 28 ) .</detailed_description>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>1 . Subject generally healthy male female , 2179 year age , inclusive . 2 . Subject BMI ≥18.50 ≤35.00 kg/m2 Visit 1 ( Day 14 ) . 3 . Subject fast LDLC level ≥130 mg/dL &lt; 190 mg/dL Visit 1 ( Day 14 ) receive drug therapy . One venous retest allow screening subject within ±3 % target range ( i.e. , minimum 126 ; maximum 196 mg/dL ) . In event redraw necessary , average two LDLC value ( redraw value Visit 1 value ) use determine eligibility . 4 . Subject fast TG &lt; 400 mg/dL Visit 1 ( Day 14 ) . One venous retest allow ≥400 mg/dL value . 5 . Subject willing maintain stable body weight , follow dietary recommendation , maintain usual physical activity throughout study period . 6 . Subject willing maintain usual physical activity level throughout trial . 7 . Subject nonuser tobacco smoking product ( include , limited cigarette , cigar , chew tobacco , ecigarettes ) plan change status study period . 8 . Subject premenopausal female history regular menstrual cycle range length 21 35 , subject postmenopausal female ( i.e. , regular menstrual cycle least one year ) . 9 . Subject health condition would prevent him/her fulfil study requirement judge Clinical Investigator basis medical history routine laboratory test result . 10 . Subject understands study procedure sign form provide informed consent participate study authorize release relevant protect health information Clinical Investigator . 1 . Subject diagnosed diabetes mellitus ( Type 1 Type 2 ) fast glucose ≥126 mg/dL screen Visit ( Visit 1 , Day 14 ) . 2 . Subject history presence uncontrolled and/or clinically important pulmonary ( include uncontrolled asthma ) , cardiac , hepatic , renal , gastrointestinal , endocrine , hematologic , immunologic , neurologic ( Alzheimer 's Parkinson 's patient ) , psychiatric ( include depression and/or anxiety disorder ) biliary disorder . 3 . Subject abnormal laboratory test result clinical significance Visit 1 ( Day 14 ) , discretion Clinical Investigator . 4 . Subject know allergy sensitivity ingredient study product . 5 . Subject extreme dietary habit ( e.g. , Atkins diet , high protein , vegetarian ) , opinion Clinical Investigator . 6 . Subject uncontrolled hypertension ( systolic blood pressure ≥160 mm Hg diastolic blood pressure ≥100 mm Hg ) define blood pressure measure Visit 1 ( Day 14 ) . One retest allow separate day prior Visit 3 ( Day 0 ) , subject abnormal blood pressure . 7 . Subject history presence cancer prior two year , except nonmelanoma skin cancer . 8 . Subject weight loss gain &gt; 4.5 kg 3 month prior Visit 1 ( Day 14 ) . 9 . Subject use medication alter lipid profile , include limited : statin , bile acid sequestrants , cholesterol absorption inhibitor , fibrates , niacin ( drug form ) , thyroid hormone , omega3 ethyl ester drug within 4 week Visit 1 ( Day 14 ; Appendix 2 ) . 10 . Subject use food dietary supplement might alter lipid metabolism , include limited : omega3 fatty acid supplement ( e.g. , flaxseed , fish , algal oil ) fortify food , sterol/stanol product ; dietary fiber supplement ( include Metamucil viscous fibercontaining supplement ) ; red rice yeast supplement ; garlic supplement ; soy isoflavone supplement ; niacin analogue dose &gt; 400 mg/d ( others discretion Clinical Investigator ) within 2 week Visit 1 ( Day 14 ; Appendix 2 ) . 11 . Subject use weightloss drug ( include overthecounter medication and/or supplement ) program within 4 week prior Visit 1 ( Day 14 , Appendix 2 ) . 12 . Subject active infection use antibiotic within 7 baseline visit ( Visits 2 3 ; Days 3 ) . 13 . Subject female , pregnant , plan pregnant study period , lactating , childbearing potential unwilling commit use medically approve form contraception throughout study period . The method contraception must record source documentation . 14 . Subject history presence diagnose severe premenstrual syndrome and/or premenstrual dysphoric disorder could interfere subject compliance . 15 . Subject initiate change use hormonal contraceptive within 90 Visit 1 ( Day 14 ) . 16 . Subject expose nonregistered drug product within 30 prior visit 1 ( Day 14 ) . 17 . Subject participate clinical trial within 4 week Visit 1 ( Day 14 ) . 18 . Subject recent history ( within 12 month screen ; Visit 1 , Day 14 ) strong potential alcohol substance abuse . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz beer , 5 oz wine , 1½ oz distil spirit ) . 19 . Subject lifestyle deem incompatible study accord Clinical Investigator include high level physical activity ( define 6 hour vigorous physical activity per week ) 20 . Individual condition Clinical Investigator believe would interfere ability provide inform consent , comply study protocol , might confound interpretation study result , put subject undue risk .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>fiber</keyword>
	<keyword>cholesterol</keyword>
</DOC>